Amyloid-β colocalizes with apolipoprotein B in absorptive cells of the small intestine

被引:36
作者
Galloway, Susan [1 ]
Takechi, Ryusuke [1 ]
Pallebage-Gamarallage, Menuka M. S. [1 ]
Dhaliwal, Satvinder S. [1 ]
Mamo, John C. L. [1 ]
机构
[1] Curtin Univ Technol, Curtin Hlth Innovat Res Inst, Sch Publ Hlth, Australian Technol Network,Ctr Metab Fitness, Perth, WA, Australia
来源
LIPIDS IN HEALTH AND DISEASE | 2009年 / 8卷
基金
英国医学研究理事会;
关键词
ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; TG2576; MICE; A-BETA; PLASMA; CHOLESTEROL; CHYLOMICRONS; LIPOPROTEIN; PURIFICATION; TRIGLYCERIDE;
D O I
10.1186/1476-511X-8-46
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Amyloid-beta is recognized as the major constituent of senile plaque found in subjects with Alzheimer's disease. However, there is increasing evidence that in a physiological context amyloid-beta may serve as regulating apolipoprotein, primarily of the triglyceride enriched lipoproteins. To consider this hypothesis further, this study utilized an in vivo immunological approach to explore in lipogenic tissue whether amyloid-beta colocalizes with nascent triglyceride-rich lipoproteins. Results: In murine absorptive epithelial cells of the small intestine, amyloid-beta had remarkable colocalization with chylomicrons (Manders overlap coefficient = 0.73 +/- 0.03 (SEM)), the latter identified as immunoreactive apolipoprotein B. A diet enriched in saturated fats doubled the abundance of both amyloid-beta and apo B and increased the overlap coefficient of the two proteins (0.87 +/- 0.02). However, there was no evidence that abundance of the two proteins was interdependent within the enterocytes (Pearson's Coefficient < 0.02 +/- 0.03), or in plasma (Pearson's Coefficient < 0.01). Conclusion: The findings of this study are consistent with the possibility that amyloid-beta is secreted by enterocytes as an apolipoprotein component of chylomicrons. However, secretion of amyloid. appears to be independent of chylomicron biogenesis.
引用
收藏
页数:7
相关论文
共 29 条
[1]  
Boyt AA, 1999, ALZHEIMERS REP, V2, P339
[2]   Elevated plasma triglyceride levels precede amyloid deposition in Alzheimer's disease mouse models with abundant Aβ in plasma [J].
Burgess, Braydon L. ;
McIsaac, Sean A. ;
Naus, Kathryn E. ;
Chan, Jeniffer Y. ;
Tansley, Gavin H. K. ;
Yang, Jing ;
Miao, Fudan ;
Ross, Colin J. D. ;
van Eck, Miranda ;
Hayden, Michael R. ;
van Nostrand, William ;
St. George-Hyslop, Peter ;
Westaway, David ;
Wellington, Cheryl L. .
NEUROBIOLOGY OF DISEASE, 2006, 24 (01) :114-127
[3]  
DAVIDSON NO, 1986, J LIPID RES, V27, P30
[4]   β-amyloid or its precursor protein is found in epithelial cells of the small intestine and is stimulated by high-fat feeding [J].
Galloway, Susan ;
Jian, Le ;
Johnsen, Russell ;
Chew, Stewart ;
Mamo, John C. L. .
JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 2007, 18 (04) :279-284
[5]   Synergistic effects of high fat feeding and apolipoprotein E deletion on enterocytic amyloid-beta abundance [J].
Galloway, Susan ;
Pallebage-Gamarallage, Menuka M. S. ;
Takechi, Ryusuke ;
Jian, Le ;
Johnsen, Russell D. ;
Dhaliwal, Satvinder S. ;
Mamo, John C. L. .
LIPIDS IN HEALTH AND DISEASE, 2008, 7 (1)
[6]   ALZHEIMERS-DISEASE - INITIAL REPORT OF THE PURIFICATION AND CHARACTERIZATION OF A NOVEL CEREBROVASCULAR AMYLOID PROTEIN [J].
GLENNER, GG ;
WONG, CW .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 120 (03) :885-890
[7]   Cholesterol modulation as an emerging strategy for the treatment of Alzheimer's disease [J].
Golde, TE ;
Eckman, CB .
DRUG DISCOVERY TODAY, 2001, 6 (20) :1049-1055
[8]   LIPID ABSORPTION AND INTESTINAL LIPOPROTEIN FORMATION [J].
GREEN, PHR ;
RILEY, JW .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1981, 11 (01) :84-90
[9]   Signposts in the assembly of chylomicrons [J].
Hussain, MM ;
Kedees, MH ;
Singh, K ;
Athar, H ;
Jamali, NZ .
FRONTIERS IN BIOSCIENCE, 2001, 6 :D320-D331
[10]   The incorporation and metabolism of amyloid-β into chylomicron-like lipid emulsions [J].
James, Anthony P. ;
Pal, Sebely ;
Gennat, Hanni C. ;
Vine, Donna F. ;
Mamo, John C. L. .
JOURNAL OF ALZHEIMERS DISEASE, 2003, 5 (03) :179-188